Recent Updates
Recently added Catalysts
VNDA Positive Sentiment Score: 75/100

Vanda Pharmaceuticals Announces Presentations at SLEEP 2023

Thursday, June 1, 2023 1 min read
Key Takeaway: Vanda Pharmaceuticals Inc. has announced its participation in SLEEP 2023, taking place in Indianapolis from June 3 to 7, 2023. The company will present multiple studies, including genetic research on delayed sleep phenotypes and the effects of iloperidone on sleep symptoms in bipolar patients. Featuring presentations by Dr. Sandra Paulina Smieszek, these studies aim to enhance understanding of sleep disorders. This active participation illustrates Vanda's commitment to advancing knowledge in sleep medicine.

Market Sentiment Analysis

POSITIVE FACTORS

  • Vanda Pharmaceuticals will present at SLEEP 2023, showcasing their research.
  • Presentations cover important topics related to sleep disorders.
  • Engagement in industry events reflects active involvement in advancing sleep medicine.

Full Press Release Details

WASHINGTON, June 1, 2023 /PRNewswire/ -- Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) today announced participation at SLEEP 2023, to be held in Indianapolis, IN from June 3 – 7, 2023.
The following will be presented:
Presentation Title: "Melanopsin Genetic Variants and Delayed Sleep Phenotype – Whole Genome Sequencing Analysis"
Presenter: Dr. Sandra Paulina Smieszek, Head of Genetics
Poster Session Presentation Time: 5:00 PM – 6:00 PM ET
Presentation Title: "Dim Light Melatonin Onset Analysis in Individuals Diagnosed with Delayed Sleep-Wake Phase Disorder (DSWPD)"
Presenter: Dr. Sandra Paulina Smieszek, Head of Genetics
Poster Session Presentation Time: 12:00 PM – 1:15 PM ET
Presentation Title: "Effect of Iloperidone on Sleep Symptoms in Bipolar Patients with Manic and Mixed Episodes: A Randomized, Placebo Controlled Study"
Presenter: Dr. Sandra Paulina Smieszek, Head of Genetics
Poster Session Presentation Time: 5:00 PM – 6:00 PM ET
For more information on SLEEP 2023, please refer to https://www.sleepmeeting.org/.
About Vanda Pharmaceuticals Inc.
Senior Vice President, Chief Financial Officer and Treasurer
Vanda Pharmaceuticals Inc.
Head of Corporate Affairs
Vanda Pharmaceuticals Inc.
SOURCE Vanda Pharmaceuticals Inc.

21 %

more press release views with

Frequently Asked Questions

What is Vanda Pharmaceuticals' participation in SLEEP 2023?

Vanda Pharmaceuticals will present at SLEEP 2023 in Indianapolis from June 3-7, 2023.

Who will present at the Vanda sessions?

Dr. Sandra Paulina Smieszek, Head of Genetics, will be the presenter.

What topics will Vanda present at the conference?

Topics include melanopsin genetic variants and sleep disorder analyses.

When will Vanda's presentations be held?

Presentations are scheduled for times ranging from 12 PM to 6 PM ET.

Where can I find more details about SLEEP 2023?

Visit https://www.sleepmeeting.org/ for more information on SLEEP 2023.

Tags: VNDA Viatris Investor Conferences Healthcare Vanda Pharmaceuticals SLEEP 2023 sleep disorders iloperidone bipolar patients
Last updated: Jun 1, 2023